Analgesia in avian species has been a long-studied topic. Pharmacokinetic and pharmacodynamic studies1–7 investigating analgesics have produced varying results. Due to the stoic nature of birds, evaluation of their pain perception is challenging. A universal pain scale has not yet been developed for use in birds, although one has been proposed for red-tailed hawks.8 Opioid drugs are commonly used in both veterinary and human analgesia and anesthesia; they are commonly indicated for traumatic or surgical pain.9 Historically, studies2,3 have supported the use of κ-agonist and µ-antagonist drugs, such as nalbuphine or butorphanol, for analgesia in psittacine species. Endogenous opioid peptides, such as β-endorphin, methionine-enkephalin, leucine-enkephalin, and dynorphin, bind to opioid receptors and mediate a wide variety of physiologic processes.10 These include the well-known roles in antinociception and analgesia but also include neuroendocrine, gastrointestinal, immune, cardiovascular, pulmonary, and cognitive functions.10,11
The distribution and relative abundance of opioid receptors within the central nervous system have been reported in a few avian species. In pigeons (Columba livia), κ-opioid receptors showed greater predominance than µ- or δ-opioid receptors in the forebrain but were distributed more equitably in the midbrain.12 In domestic chicks (Gallus domesticus), the µ-opioid receptor was predominantly expressed in the forebrain and midbrain.13 In a recent study14 comparing opioid receptor distribution in cockatiels and pigeons, there were higher levels of µ-opioid receptor 1 (OPRM1) than κ-opioid receptor 1 (OPRK1) reported in the brains of both species. Multiple autoradiographic studies15–17 have been performed in the junco (Junco hyemalis), examining opioid receptor abundance in the vocal centers and the hypothalamus. Zebra finch (Taenopygia guttata) song control regions have been examined using PCR, in situ hybridization, immunoblotting, and immunohistochemistry to determine the relative abundance of µ and δ receptors.18 In that study,18 there was higher expression of μ-opioid receptor mRNA than δ-opioid receptor mRNA in the lateral magnocellular nucleus of the anterior nidopallium, Area X, medial striatum, hyperstriatum ventrale, and robust nucleus of the arcopallium. The genetic structures of µ-, κ-, and δ-opioid receptors have also been published19 for the peregrine falcon (Falco peregrinus), snowy owl (Bubo scandiacus), and blue-fronted Amazon parrot (Amazona aestiva). To the author's knowledge, there have been no published reports investigating the distribution of opioid receptors in the central nervous system of a psittacine species.
Budgerigars (Melopsittacus undulatus) are the third most popular pet in the world after the dog and cat and have been domesticated for approximately 150 years. They are also one of the few psittacine species with a completely sequenced genome and brain atlas, both of which are publicly available.20,21 Budgerigars are used as a model for vocal learning, so many researchers are familiar with their nervous system, and they are therefore a useful model for studying the central nervous system in birds.22
Fluorescent in situ hybridization (FISH) is an older technology that has seen a resurgence in recent years with the advent of highly sensitive and specific probes that can target mRNA, DNA, and proteins. Historically, FISH provided inconsistent results and was highly dependent on experimental conditions and viewer interpretation.23 Autoradiography, a technique using radiographic film to visualize molecules that have been radioactively labeled, was instead used to quantify the number of opioid receptors within nervous tissue using radioactive probes.13 These radionuclide probes are effective but may be time consuming, carcinogenic, and pose unnecessary health risks to operators.23 The use of RNA hybridization probes (RNAscope; Advanced Cell Diagnostics Inc) is a novel method by which single molecules in individual cells can be observed using hybridization-based signal amplification. Frozen or fixed tissue can be used to identify mRNA molecules within cells. Messenger RNA-specific probes are developed or selected from a catalog that attaches to the strands of mRNA of interest. These probes then bind to fluorophores, which can then be visualized using a fluorescent microscope.24 This method strengthens signals produced by fluorescent probes while simultaneously suppressing background noise. Multiple DNA, RNA, or protein targets may be visualized during the same assay. This method also provides greater sensitivity and specificity than previous FISH methods; this is achieved through the use of 2 independent probes that hybridize on the same molecule to achieve signal amplification.24 This method of in situ hybridization has been utilized in zebra finches previously to investigate a potassium-chloride cotransporter in the vocal control center.25 The purpose of the study reported here is to identify µ- and κ-opioid receptor distribution within selected areas of the forebrain and midbrain of the budgerigar using FISH.
Materials and Methods
Twenty-three budgerigars housed at a zoological institution died in an acute mortality event. The animals were housed in a barn with exposure to a portable propane heater. They consumed ad libitum seed and pelleted mixture diet. Necropsies revealed no clinically important findings other than pulmonary hemorrhage, consistent with the highly suspected carbon monoxide toxicosis. Brains were collected from 8 adult males of varying ages within 48 hours after death. They were immediately frozen on dry ice at –78°C and were stored at –80°C as per a published protocol,26 until the study could be performed. Brains were equilibrated to –20°C for 1 hour to create 6 section blocks per brain with a No. 10 scalpel. They were placed in optimal cutting temperature media and immediately frozen with liquid nitrogen. Blocks were stored at –80°C until sectioned and were once again equilibrated to –20°C. Sixteen-micrometer-thick coronal sections were produced with a cryostat (Microm Microtome Cryostat HM505e; Carl Zeiss Jena GmbH) and placed onto slides (Fisherbrand Superfrost Plus; Fisher Scientific), which were stored at –80°C (Figure 1). The FISH assays were performed on all 8 brains within 6 months of initial brain sampling.
The FISH protocol was carried out per the manufacturer's instructions (RNAscope Multiplex Fluorescent Reagent Kit v2 Assay 2019; Advanced Cell Diagnostics Inc). Sections were treated with hydrogen peroxide and protease and then incubated with 2 sets of 20 custom-designed RNA-based double Z target probe pairs. One set of probe pairs targeted the adjacent 18 to 25 base regions within the target sequence 2-1063 of XM_005150073.1 against the budgerigar μ-opioid receptor mRNA, or OPRM1 (Melopsittacus undulatus-LOC101868267; Advanced Cell Diagnostics). The other set of probe pairs targeted the adjacent 18 to 25 base regions within the target sequence 113 to 1332 of XM_005152549.2 against the budgerigar κ-opioid receptor mRNA, or OPRK1 (Melopsittacus undulatus-LOC101880502-C2; Advanced Cell Diagnostics). A positive control probe was designed for the purposes of this study, which targeted the FOXP2 gene in the medial striatum. The 20 RNA-based double Z target probe pairs targeted the adjacent 18 to 25 base regions within the target sequence 1286 to 2406 of NM_001281546.1 against FOXP2 (Melopsittacus undulatus-FOXP2; Advanced Cell Diagnostics). The expression of FOXP2 mRNA in budgerigars is known and documented in multiple in situ hybridization studies.27,28
For the FISH study, sections were incubated in probe solution for 2 h at 40°C and then washed and incubated (40°C each time) in sequence with 4 additional amplifying solutions per manufacturer's instructions. A pretreatment reagent (Protease Plus; Advanced Cell Diagnostics Inc) was utilized to digest the cell material. After initial results revealed extensive digestion, the manufacturer's recommended digestion time was reduced by 5 minutes. By reducing protease digestion time, visualization of cell architecture and opioid receptor distribution was improved. Slides were tested for the integrity of their RNA using the probe specific to FOXP2 mRNA. The negative control was determined using a probe specific to the bacterial DapB gene from the Bacillus subtilis strain SMY, a soil bacterium. There was < 1 dot of label per cell when stained with the negative control probe.
Dyes (Opal 520 and Opal 570; PerkinElmer Inc) were used as the fluorophores for µ- and κ-opioid receptor RNA, respectively. The fluorophore dye for µ-opioid receptor RNA fluoresces with a wavelength of 494 to 525 nm, producing a green emission, whereas the fluorophore dye for κ-opioid receptor RNA fluoresces with a wavelength of 550 to 570 nm, producing an orange emission. These colors are easily distinguishable in fluorescent microscopy, so misinterpretation is unlikely. A nuclear counterstain, 4′,6-diamidino-2-phenylindole, was used to facilitate visualization of landmarks on the slides, as it stains nuclear DNA and emits blue light at wavelengths of 358 to 461 nm. Slides were kept in the dark at 4°C until they could be imaged. Imaging of fluorescently labeled tissue was performed between 8 hours and 2 weeks after conclusion of the assay, consistent with manufacturer's recommendations, using a camera (Olympus Q-color camera; Olympus Corp) with a fluorescent microscope (BX51 Olympus microscope; Olympus Corp). Images were collected at 40X, 100X, and 400X magnification using image-capturing software (Image ProPremier; Media Cybernetics Inc). Histology was performed on normal budgerigar brains to compare anatomic locations of µ- and κ-opioid receptors. All images were obtained and reviewed by the same person (P.A.S.) to ensure consistency in interpretation.
Results
The use of mRNA probes created and utilized with FISH assays for determination of µ- and κ-opioid receptor distribution worked as expected and permitted visualization using a standard fluorescent microscope (Figures 2–5). The positive and negative control probes also worked as expected. Locations within the budgerigar brain were compared with images reported by the Brauth Lab at the University of Maryland.21 Structures of the avian telencephalon and diencephalon were labeled and described using updated nomenclature.29 The probes utilized for this study had different affinities for each receptor type, so the signal intensity of µ- and κ-opioid receptors can only be compared to themselves and not to each other (Figure 2). Each dot, or signal, is a visualization of a molecule of mRNA. The brains examined did show a very similar distribution pattern of µ- and κ-opioid receptors. However, due to financial and sampling constraints, only a limited number of assays could be performed, making this a purely qualitative study.
There was κ-opioid receptor mRNA present in the lateral nucleus dorsomedialis posterior thalami, lateral striatum, mesopallium, tractus corticohabenularis et corticoseptalis, griseum et fibrosum, stratum griseum centrale, medial striatum, and area parahippocampalis (Figures 3–5).
There was µ-opioid receptor mRNA present in the stratum griseum centrale, stratum opticum, nucleus dorsomedialis posterior thalami, area parahippocampalis, medial striatum, nidopallium intermedium, lateral striatum, and tractus corticohabenularis et corticoseptalis (Figures 3–5).
Discussion
To the authors’ knowledge, this was the first published use of FISH assays to characterize µ- and κ-opioid receptors of selected areas of any psittacine forebrain and midbrain. The data support the clinical impression that many psittacine birds have an analgesic response to κ-opioid receptor agonist and µ-opioid antagonist drugs, which is contrary to what is observed in most mammalian species. The findings reported herein are most consistent with those observed in earlier pigeon studies, that there is a higher relative predominance of κ- over µ-opioid receptors in the forebrain but no relative predominance in the midbrain.12 Conversely, in the day-old chick forebrain and midbrain, µ-opioid receptors predominate over κ-opioid receptors.13 Semiquantitative analysis can be performed using the RNA hybridization probes and FISH assay protocol but was beyond the scope of this investigation.30,31
This study was facilitated by the publication of the budgerigar genome. This information allowed for the development of highly sensitive and specific probes for µ- and κ-opioid receptor mRNA specific for this species. There are known variations in the mRNA sequence of opioid receptors in multiple species.19 However, the method of FISH used in this study limits the risk of both false positive and false negative results, ensuring that the signals observed actually represent κ- and µ-opioid receptor mRNA.24
The nomenclature for the avian brain has changed since the early opioid distribution studies to reflect the more appropriate embryonic origins of the avian brain.29 Recent research32 has shown that the avian brain has a very unique organizational pattern, consisting of compartmentalized nuclear groupings. The striatum is composed predominantly of inhibitory GABAergic neurons that project to GABAergic neurons in the pallium.33 The µ- and κ-opioid receptor distribution of the striatum was examined in this study. The medial striatum is partially responsible for the processing of sensory-motor information for the production and integration of auditory, visual, and singing behaviors. It is also partially responsible for food, water, sex-related reward, and motivation of appetite.33 The lateral striatum participates in visual information processing.33 Other regions of the avian brain are still being better characterized.
The avian brain is unique when compared to the mammalian brain, especially in regards to the cerebrum. The avian cerebrum is composed of a nuclear pallium, while the mammalian brain is arranged as a laminar cortex.32–34 Homologies with birds are still uncertain for most of the telencephalic pallium in birds, so a direct one-to-one comparison is not possible.29 Even among mammals, there may be substantial differences in opioid receptor mRNA distribution. In studies35,36 of human (Homo sapiens) and rat (Rattus norvegicus), µ- and κ-opioid receptor mRNA distribution showed similar but not equivalent distribution, suggesting caution with regard to direct comparison even between related species.
A positive control probe was designed specifically for this study, as one was not readily available for psittacine birds using RNA hybridization probe and FISH assay technology. Housekeeping genes are usually utilized for this purpose, as they are present in most tissues being studied, such as the GAD2 gene in zebra finches.37 The FOXP2 gene has been linked to human speech and vocal plasticity.27 This gene has been reported as being present in the medial striatum of the budgerigar and was therefore chosen as the control for this study.27,28 Unfortunately, due to its location only within the medial striatum, obtaining a representative coronal section including the medial striatum proved difficult. Future FISH investigations should utilize a housekeeping gene that is more readily distributed throughout the budgerigar brain.
Previously published in situ hybridization protocols15,25,37 report that the interval between death and freezing of tissues should be just minutes. Brains were collected within 48 h of death. The cause of death in the birds that were used in this study was consistent with carbon monoxide poisoning. Carbon monoxide is an odorless, colorless gas that is not flammable or explosive at concentrations < 12% and readily causes a fatal hypoxemia with prolonged exposure.38 Carbon monoxide has been deemed an appropriate method of euthanasia if proper safety measures occur to prevent human exposure.38 The mass mortality situation that occurred is too uncontrolled to be an appropriate method of euthanasia to perform in a repeat scenario. In a study39 comparing poultry euthanasia methods during an avian influenza epidemic, all birds died within 2 h when exposed to 1.5% to 2% carbon monoxide. This noxious gas induces a loss of consciousness without pain and with minimal discernible discomfort due to its insidious nature. Death should occur rapidly if birds are exposed to concentrations of 4% to 6%.40 Recent research41 suggests that carbon monoxide gas may be useful as a local antinociception agent. In mammals, multiple studies40,42 have shown endogenous carbon monoxide inhibits inflammation, acute nociception, and neuropathic pain. However, due to the short agonal interval and high doses of carbon monoxide, gene expression is unlikely to be affected.
Despite RNA remaining stable for only a few hours in a live specimen, RNA appears to become more stable in the postmortem period.43 A number of mechanisms have been hypothesized for this profound difference, including reduced RNase activity, increased longevity of endogenous RNase inhibitors, and a decreased susceptibility to degradation of RNA when translation stops.43 There is progressive RNA degradation over time with no genes in the human shown to have significantly increased expression with an increase in postmortem interval.44 The means with which death occurred can also cause substantial alterations in brain pH and stability of RNA.45 An agonal scoring system has been developed in humans to help determine how much physiologic change may have occurred in the postmortem brain but has not been applied to animal species.45 Ribonucleases (RNases) can become more active in agonal states, breaking down RNA, which would otherwise be stable in the patient postmortem.45 Total RNA within the brain has been reported as being stable in multiple species for 24 to 48 hours, including humans, mice, rats, and pigs.43, 46 The stability of brain tissue for use in FISH studies has also been shown to remain intact for as long as 33 months after the initial freezing without loss of mRNA.47 The spinal cord, by contrast, should be dissected and frozen rapidly due to the high concentration of RNases present within the tissue.46 For further determination of mRNA stability, pH can be measured. A lower pH would facilitate RNA degradation and is most commonly observed in agonal patients.45
Male specimens were chosen for this study to limit variability by comparing opioid receptor mRNA differences between sexes. Also, budgerigars are sexually dimorphic, and males can be easily identified by their light blue cere. One large difference between the sexes is the act of courtship whereby males utilize song to attract a female mate. Endogenous opioids modulate motivated behaviors, and methionine-enkephalin and leucine-enkephalin have been found in some regions of the song control pathway of zebra finches (Taenopygia guttata), such as Area X.48,49 Area X is not an area present in the budgerigar brain,21 and the vocal pathways of budgerigars and songbirds are only superficially similar.50 Further studies comparing the male and female budgerigar brain would be necessary to determine if sex plays a role in opioid receptor mRNA distribution.
The distribution of the δ-opioid receptor was not included in the scope of this study. The function of the δ-opioid receptor in avian species is still unclear, but its distinction from the µ-opioid receptor is important. The δ-opioid receptor is widely expressed in the central and peripheral nervous system, usually found in different cell types than the µ-opioid receptor. It may also be more efficacious in inflammatory, neuropathic, and chronic pain than µ-opioid receptors, which are more effective in acute pain.51 Animal models have also shown anxiolytic and antidepressant effects with δ-opioid receptor stimulation that have not been observed with µ-opioid receptors.52 Multiple drugs have been developed targeting the δ-opioid receptor specifically, but none are commercially available at present.51
This study helps reaffirm the knowledge that the opioid distribution of avian species is very different from mammals. Utilizing FISH to identify opioid receptor distribution in the forebrain and midbrain is both safe and effective. Further studies in multiple avian species can clarify differences in physiologic response to opioid administration.
Acknowledgments
The authors declare that there were no conflicts of interest.
The authors thank the Companion Animal Fund at the University of Tennessee College of Veterinary Medicine for their generous grant and Advanced Cell Diagnostics for technical support and assistance throughout the project, including designing novel probes for this investigation. We also thank the Vascular Research Laboratory at the University of Tennessee Health Science Center for assistance in utilizing the cryotome and fluorescent microscope.
Preliminary data from this manuscript were presented as an abstract at the Association of Avian Veterinarians Virtual Conference 2020 on November 14, 2020.
References
- 1.↑
Gustavsen KA, Guzman DS, Knych HK, Petritz OA, Olsen GH, Paul-Murphy JR. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius). Am J Vet Res. 2014;75(8):711–715.
- 2.↑
Guzman DS, Flammer K, Paul-Murphy JR, Barker SA, Tully TN Jr. Pharmacokinetics of butorphanol after intravenous, intramuscular, and oral administration in Hispaniolan Amazon parrots (Amazona ventralis). J Avian Med Surg. 2011;25(3):185–191.
- 3.↑
Guzman DS, KuKanich B, Keuler NS, Klauer JM, Paul-Murphy JR. Antinociceptive effects of nalbuphine hydrochloride in Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res. 2011;72(6):736–740.
- 4.
Hawkins MG, Pascoe PJ, Knych HK, Drazenovich TL, Kass PH, Guzman DS. Effects of three fentanyl plasma concentrations on the minimum alveolar concentration of isoflurane in Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res. 2018;79(6):600–605.
- 5.
Hoppes S, Flammer K, Hoersch K, Paul-Murphy J. Disposition and analgesic effects of fentanyl in white cockatoos (Cacatua alba). J Avian Med Surg. 2003;17(3):124–130.
- 6.
Pascoe PJ, Pypendop BH, Phillips JC, Knych HK, Guzman DS, Hawkins MG. Pharmacokinetics of fentanyl after intravenous administration in isoflurane-anesthetized red-tailed hawks (Buteo jamaicensis) and Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res. 2018;79(6):606–613.
- 7.↑
Paul-Murphy J, Hess JC, Fialkowski JP. Pharmacokinetic properties of a single intramuscular dose of buprenorphine in African grey parrots (Psittacus erithacus erithacus). J Avian Med Surg. 2004;18(4):224–228.
- 8.↑
Mazor-Thomas JE, Mann PE, Karas AZ, Tseng F. Pain-suppressed behaviors in the red-tailed hawk (Buteo jamaicensis). Appl Anim Behav Sci. 2014;152:83–91.
- 9.↑
Paul-Murphy J, Hawkins MG. Bird-specific considerations: recognizing pain behavior in pet birds. In: Gaynor JS, Muir WW III, eds. Handbook of Veterinary Pain Management. 3rd ed. Mosby/Elsevier; 2015:536–554.
- 10.↑
Scanes CG, Pierzchala-Koziec K. Perspectives on endogenous opioids in birds. Front Physiol. 2018;9:1842.
- 11.↑
Douglas JM, Guzman DS, Paul-Murphy JR. Pain in birds: the anatomical and physiological basis. Vet Clin North Am Exot Anim Pract. 2018;21(1):17–31.
- 12.↑
Reiner A, Brauth SE, Kitt CA, Quirion R. Distribution of mu, delta, and kappa opiate receptor types in the forebrain and midbrain of pigeons. J Comp Neurol. 1989;280(3):359–382.
- 13.↑
Csillag A, Bourne RC, Stewart MG. Distribution of mu, delta, and kappa opioid receptor binding sites in the brain of the one-day-old domestic chick (Gallus domesticus): an in vitro quantitative audioradiographic study. J Comp Neurol. 1990;302(3):543–551.
- 14.↑
Fousse SL, Golsen BM, Guzman DS, Paul-Murphy JR, Stern JA. Varying expression of mu and kappa opioid receptors in cockatiel (Nymphicus hollandicus) and domestic pigeons (Columba livia domestica). Front Genet. 2020;11:549558.
- 15.↑
Deviche P, Cotter P, Gulledge CC. Identification, partial characterization, and hypothalamic distribution of κ, µ, and δ opioid receptors in a passerine songbird (Junco hyemalis). Brain Res. 1993;614:220–226.
- 16.
Gulledge CC, Deviche P. Autoradiographic localization of opioid receptors in vocal control regions of a male passerine bird (Junco hyemalis). J Comp Neurol. 1995;356(3):408–417.
- 17.↑
Gulledge CC, Deviche P. Age- and sex-related differences in opioid receptor densities in the songbird vocal control system. J Comp Neurol. 1999;404(4):505–514.
- 18.↑
Khurshid N, Agarwal V, Iyengar S. Expression of mu- and delta-opioid receptors in song control regions of adult male zebra finches (Taenopygia guttata). J Chem Neuroanat. 2009;37(3):158–169.
- 19.↑
Duhamelle A, Raiwet DL, Langlois I, Fitzgerald G, Silversides DW. Preliminary findings of structure and expression of opioid receptor genes in a peregrine falcon (Falco peregrinus), a snowy owl (Bubo scandiacus), and a blue-fronted Amazon parrot (Amazona aestiva). J Avian Med Surg. 2018;32(3):173–184.
- 20.↑
Ganapathy G, Howard JT, Ward JM, et al. High-coverage sequencing and annotated assemblies of the budgerigar genome. GigaScience. 2014;3:11.
- 21.↑
Brauth SE, Heaton JT, Roberts TF, Liang W. Budgerigar brain atlas. Department of Psychology, University of Maryland. Accessed January 29, 2022. http://www.brauthlab.umd.edu/atlas.htm
- 22.↑
Brauth S, Liang W, Roberts TF, Scott LL, Quinlan EM. Contact call-driven Zenk protein induction and habituation in telencephalic auditory pathways in the budgerigar (Melopsittacus undulatus): implications for understanding vocal learning processes. Learn Mem. 2002;9(2):76–88.
- 23.↑
Levsky JM, Singer RH. Fluorescence in situ hybridization: past, present and future. J Cell Sci. 2003;116(14):2833–2838.
- 24.↑
Wang F, Flanagan J, Su N, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14(1):22–29.
- 25.↑
Vaaga CE, Miller KE, Bodor ÁL, Perkel DJ. Expression of the potassium-chloride co-transporter, KCC2, within the avian song system. J Comp Neurol. 2018;526(6):944–956.
- 26.↑
Wisden W, Morris BJ. In situ hybridization with oligonucleotide probes. In: Wisden W, Morris BJ, eds. In Situ Hybridization Protocols for the Brain. 2nd ed. Academic Press; 2002:3–59.
- 27.↑
Haesler S, Wada K, Nshdejan A, et al. FoxP2 expression in avian vocal learners and non-learners. J Neurosci. 2004;24(13):3164–3175.
- 28.↑
Whitney O, Voyles T, Hara E, Chen Q, White SA, Wright TF. Differential FoxP2 and FoxP1 expression in a vocal learning nucleus of the developing budgerigar. Dev Neurobiol. 2015;75(7):778–790.
- 29.↑
Reiner A, Perkel DJ, Bruce LL, et al. Revised nomenclature for avian telencephalon and some related brainstem nuclei. J Comp Neurol. 2004;473(3):377–414.
- 30.↑
Jolly S, Lang V, Koelzer VH, et al. Single-cell quantification of mRNA expression in the human brain. Sci Rep. 2019;9:12353.
- 31.↑
Kersigo J, Pan N, Lederman JD, et al. A RNAscope whole mount approach that can be combined with immunofluorescence to quantify differential distribution of mRNA. Cell Tissue Res. 2018;374(2):251–262.
- 32.↑
Nomura T, Izawa E. Avian brains: insights from development, behaviors and evolution. Dev Growth Differ. 2017;59(4):244–257.
- 33.↑
Kumar S, Iyengar S. Avian striatal complex. In: Vonk J, Shackelford TK, eds. Encyclopedia of Animal Cognition and Behavior. Living ed. Springer Nature AG; 2018:1–6.
- 34.↑
Jarvis ED, Güntürkün O, Bruce L, et al. Avian brains and a new understanding of vertebrate brain evolution. Nat Rev Neurosci. 2005;6(2):151–159.
- 35.↑
Mansour A, Fox CA, Burke S, et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol. 1994;350(3):412–438.
- 36.↑
Peckys D, Landwehrmeyer GB. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience. 1999;88(4):1093–1135.
- 37.↑
Carleton JB, Lovell PV, McHugh A, Marzulla T, Horback KL, Mello CV. An optimized protocol for high-throughput in situ hybridization of zebra finch brain. Cold Spring Harb Protoc. 2014;2014(12):1249–1258.
- 38.↑
Leary S, Underwood W, Anthony R, et al. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. AVMA; 2020.
- 39.↑
Gerritzen MA, Lambooij E, Stegeman JA, Spruijt BM. Slaughter of poultry during the epidemic of avian influenza in the Netherlands in 2003. Vet Rec. 2006;159(2):39–42.
- 40.↑
Carcolé M, Castany S, Leánez S, Pol O. Treatment with a heme oxygenase 1 inducer enhances the antinociceptive effects of µ-opioid, δ-opioid, and cannabinoid 2 receptors during inflammatory pain. J Pharmacol Exp Ther. 2014;351(1):224–232.
- 41.↑
Fan W, Huang F, Wu Z, Zhu X, Li D, He H. Carbon monoxide: a gas that modulates nociception. J Neurosci Res. 2011;89(6):802–807.
- 42.↑
Castany S, Carcolé M, Leánez S, Pol O. The induction of heme oxygenase 1 decreases painful diabetic neuropathy and enhances the antinociceptive effects of morphine in diabetic mice. PLoS One. 2016;11(1):e0146427.
- 43.↑
Barton AJ, Pearson RC, Najlerahim A, Harrison PJ. Pre- and postmortem influences on brain RNA. J Neurochem. 1993;61(1):1–11.
- 44.↑
Birdsill AC, Walker DG, Lue L, Sue LI, Beach TG. Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank. 2011;12(4):311–318.
- 45.↑
Tomita H, Vawter MP, Walsh DM, et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry. 2004;55(4):346–352.
- 46.↑
Revilla A, Jones A. Cryostat sectioning of brains. In: Wisden W, Morris BJ, eds. In Situ Hybridization Protocols for the Brain. 2nd ed. Academic Press; 2002:61–70.
- 47.↑
Harrison PJ, Heath PR, Eastwood SL, et al. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett. 1995;200(3):151–154.
- 48.↑
Carrillo GD, Doupe AJ. Is the songbird Area X striatal, pallidal, or both? An anatomical study. J Comp Neurol. 2004;473(3):415–437.
- 49.↑
Khurshid N, Jayaprakash N, Hameed LS, Mohanasundaram S, Iyengar S. Opioid modulation of song in male zebra finches (Taenopygia guttata). Behav Brain Res. 2010;208(2):359–370.
- 50.↑
Striedter GF. The vocal control pathways in budgerigars differ from those in songbirds. J Comp Neurol. 1994;343(1):35–56.
- 51.↑
Charles A, Pradhan AA. Delta-opioid receptors as targets for migraine therapy. Curr Opin Neurol. 2016;29(3):314–319.
- 52.↑
Pradhan AA, Befort K, Nozaki C, Gavériaux-Ruff C, Kieffer BL. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci. 2011;32(10):581–590.